微泰医疗器械（杭州）股份有限公司（02235）于2025年11月19日更新翌日披露报表，宣布当天回购股份共计101,400股，占已发行股本（不包括库藏股）约0.0609%。此次回购价格区间介于每股6港元至6.5港元，总金额约为63.48万港元。
公告显示，回购完成后，公司于2025年11月19日的已发行股本合计169,175,842股，其中166,522,242股为已发行在外股份，另持有库藏股2,653,600股。该次回购基于公司于2025年5月28日获得的回购授权，授权范围为16,668,364股。
公司确认本次交易已经过董事会正式批准，并遵守相关上市规则和法律规定。公告由执行董事及联席公司秘书施永辉签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.